Chemokine Ligand 5 (CCL5) and chemokine receptor (CCR5) genetic variants and prostate cancer risk among men of African Descent: a case-control study.

Hered Cancer Clin Pract · 2012 · PMC3527309 · PMID 23168091

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

marginally significantno p-value reported

After controlling for multiple comparisons, the dominant genetic models for the two CCL5 SNPs (rs2107538, rs3817655) remained significant with false-discovery rates (FDR) ≤ 0.0150; whereas, the recessive genetic model for CCR5 rs1799988 was marginally significant (FDR = 0.0494).

also in 26,082 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.